Healthcare M&A and Valuation
News and Insights

On December 15, 2025, Cencora, Inc. (NYSE: COR) announced a definitive agreement to acquire  the majority of the outstanding equity interests it does not already own in OneOncology, a physician‑led national oncology platform that empowers independent cancer care practices, from private equity firm TPG and other shareholders. The purchase price was approximately $3.6 billion in cash plus retirement of ~$1.3 billion of existing corporate debt, implying total cash consideration

On August 15, 2025, Cardinal Health (NYSE: CAH)  announced its acquisition  of Solaris Health, the leading urology‑focused management services organization (MSO) in the U.S., in a strategic transaction valued at approximately $1.9 billion in cash consideration, with additional equity rollover bringing implied total deal value closer to $2.4 billion. The deal expands Cardinal’s multi‑specialty MSO platform, The Specialty Alliance, by adding more than 750 providers across 250+

Healthcare drug distributor Cencora has purchased Retina Consultant of America for $4.6 billion. RCA is (by far) the largest MSO in the...